Frontlight ResearchEarly access
CompletedNo phase
Quality of Life Evaluation After Cataract Surgery Using 4 Types of Intraocular Lens Implant Combinations
Key facts
- Who runs it
- Centre Hospitalier Régional Metz-Thionville
- Where
- France2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 200 people enrolled
- Started
- 30 Jan 2023
- Ended
- 21 May 2025
- Type of study
- Interventional, 4 groups
- Treatments tested
- Zeiss CT Asphina / Zeiss CT Asphina
- Zeiss AT Lara/ Zeiss AT Lisa Tri
- Zeiss CT Asphina/ Zeiss AT Lara
- Zeiss AT Lara / Zeiss AT Lara
- Record updated
- 28 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (31)Hide the full registry criteria
Who can take part
- Patient suffering from bilateral cataract and undergoing cataract surgery
- Patient with preoperative visual acuity ≤ 8/10th Monoyer (≥+ 0.1 logMar) in each eye
- Patient with nuclear color (NC), cortical (C) or posterior capsule opacity (P) cataract of normal to severe density in the Lens Opacities Classification System III (LOCSIII)
- Patient with cortical cataracts classified C1 to C5
- Patient with cataracts classified as nuclear opalescence (NO)1 to NO4 and nuclear color (NC)1 to NC4
- Patient with posterior capsule opacity cataracts classified as grade 5 (P1-P5)
- Patient affiliated to a social security scheme
- Patient having given written consent
Who cannot take part
- Patient with a history (ATCD) of refractive surgery
- Patient with ATCD intraocular surgery
- Patient with progressive or old ocular inflammatory disease
- Patient with pseudoexfoliative syndrome
- Patient with age-related macular degeneration (AMD)
- Patient with biometrics ≤ 17 Diopters (D) and ≥ 28D
- Patient with ATCD strabismus
- Patient with amblyopia
- Patient with monophthalmos
- Patient with glaucoma
- Patient with diabetic retinopathy or maculopathy
- Patient presenting with a very dense nuclear cataract (Stage NO5-6, NC5-6 on the LOCSIII classification), sources of preoperative complication
- Patient with keratoconus
- Patient with pigment dispersion
- Patient with traumatic cataract
- Patient with astigmatism conforming to the rule > 1.5 Diopters (D) or inverse to the rule > 1 Diopter (D)
- Patient with abnormal ocular morphology
- Patient with abnormal keratometry
- Insulin-dependent diabetics and/or diabetics with retinal complications
- Pregnant or breastfeeding women
- Patient under legal protection (guardianship, curators, safeguard of justice)
- Person deprived of liberty
- Patient wishing to see near or far exclusively
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is multicenter, prospective, comparative and randomized study focusing on the evolution of the quality of Life and Uncorrected Binocular Visual Acuity (UBVA) evaluation at 3 months after cataract surgery in patients who underwent 4 different types of intraocular lens Implant (IOL) combinations.
The 4 groups in the trial
- Zeiss CT Asphina / Zeiss CT AsphinaTreatment being tested
Monovision with refractive target of -1.50 Diopters (D) on the dominated eye
- Zeiss AT Lara/ Zeiss AT Lisa TriTreatment being tested
Zeiss AT Lara (dominant eye) / Zeiss AT Lisa Tri (non-dominant eye)
- Zeiss CT Asphina/ Zeiss AT LaraTreatment being tested
Zeiss CT Asphina/ Zeiss AT Lara (non-dominant eye)
- Zeiss AT Lara / Zeiss AT LaraTreatment being tested
Micro-monovision with refractive target of -0.75 Diopters (D) on the non-dominant eye
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Quality of Life and Uncorrected Binocular Visual Acuity (UBVA) Evaluation in Patients Undergoing Cataract Surgery Using 4 Different Types of Lens Implant Combinations: a Multicenter, Prospective, Comparative and Randomized Study
- Record updated
- 28 May 2025